News

Therapure said that it will apply its experience and knowledge in cell culture and in the design and development of scaled-up biologic manufacturing processes to advance the initial

As CFO, Mr Coughlen will be responsible for all aspects of PolyRemedy’s finance function, including accounting, financial planning and analysis, and internal policy development. In addition, Mr Coughlen

Investors in the round included Piper Jaffray, Arnerich Massena & Associates, Medtronic, RiverVest Venture Partners, and other financial and strategic investors. Salient plans to use the net proceeds

Heilongjiang Tianlong Pharmaceutical Company, a subsidiary of China Sky One Medical, will purchase the breast drug for RMB10 million from Harbin Medical University. China Sky One Medical collaborated

The data demonstrated that tgAAC94, an investigational agent designed to inhibit activity of tumor necrosis factor-alpha (TNF-alpha), a key mediator of inflammation, is well tolerated and may improve

Specially engineered to complement the existing offering of Cook embolization products and coils, MiraFlex high flow embodies the latest innovation in microcatheter technology designed to enhance traceability necessary

The product delivers PTH 1-34, teriparatide (PTH), a compound that has been proven to stimulate formation of new bone and reduce the risk of fractures. The ZP-PTH patch

The license grants Galenea the exclusive worldwide rights to develop, manufacture and commercialize the novel indole-based agonists, said Galenea. The licensed compounds have demonstrated potent 5-HT2C receptor agonist

When approved, the OraQuick hepatitis C virus (HCV) test is expected to be the first rapid HCV test approved by the FDA for use in the US. The